August 15, 2024
HistoSonics Announces Oversubscribed $102 Million Series D Financing to Scale Launch of Non-Invasive Histotripsy Platform
Funding to Advance New Histotripsy Applications and Launch Innovative BOOMBOX Master Study HistoSonics Edison® Histotripsy System (Photo: Business Wire) August 15, 2024 08:00 AM Eastern Daylight Time MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, the…
June 25, 2024
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes
Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with…
May 22, 2024
A top Research Triangle based venture capital investor shares an overview of the life sciences ecosystem in North Carolina.
Hatteras Venture Partners' Clay Thorp describes the growth of North Carolina's biotech industry during his firm's 20+ years of experience, and describes what the region does well and what are…
January 24, 2024
The Robert A. Ingram Fellowship for Excellence in Board Governance
The NACD Research Triangle Chapter, together with RTI International, is delighted to announce a fellowship award in honor of Robert A. Ingram, acknowledging his exceptional commitment to excellence in board…
July 25, 2023
Shionogi Further Extends Infectious Disease Innovation Platform with Planned Acquisition of Qpex Biopharma, Inc.
Acquisition brings access to a novel investigational ß-lactamase inhibitor, expanding pipeline of critically needed antimicrobials, and further augments R&D capabilities and expertise OSAKA, Japan, June 26, 2023 - Shionogi & Co.,…
May 18, 2023
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
Financing accelerates MT-302, the Company’s first clinical candidate for in vivo cell programming, into a Phase 1/2 clinical trial for TROP2+ solid tumors CAMBRIDGE, Mass., May 18, 2023 – Myeloid…
May 3, 2023
NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease
For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has been a routine part of the care he provides to his patients with fecal incontinence.…
April 3, 2023
It is with the heaviest of hearts that we mourn the passing of our partner, mentor, and friend – Robert A. Ingram
Bob was the most giving of people, who always had the time and focus to make you feel like you were his only concern. As the leader of GlaxoWellcome, he…
December 8, 2022
Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease
CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series…
September 19, 2022
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery Signs Definitive Agreement to Acquire Standard Bariatrics WAYNE, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) --…